Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. L.C.L.T. (Léon) van Kempen
University Medical Center Groningen

dr. L.C.L.T. (Léon) van Kempen

Klinisch Moleculair Bioloog in de Pathologie
Profielfoto van dr. L.C.L.T. (Léon) van Kempen
Telefoon:
050 361 5129 (Office)
Staff assistant:
050 361 0020 (Mrs. Annet Bouman - Van der Jagt)
E-mail:
l.van.kempen umcg.nl

Research interests

Clinical Scientist in Molecular Pathology, molecular diagnostic service. 

Research interests: Molecular biology and pathology of melanoma and non-small cell lung cancer. 

Publicaties

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

Increased interferon signalling in vaginal tissue of patients with primary Sjögren's syndrome

The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy

95P Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland

Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

Formalin-Fixed, Paraffin-Embedded–Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors

Lees meer

Pers/media

NanoString Launches nCounter TCR Diversity Panel and Analysis Package at th

NVVP magazine 2021-01

Moleculaire diagnostiek voor de detectie van RET- en NTRK-fusies bij kanker

Successful Molecular Tumor Board

Effectiveness of the UMCG Molecular Tumor Board

Detectie van fusiegenen: kwaliteitscontrole en nieuwe methodologie

Moleculaire Tumor Boards

cBioportal at HealtRI

Opening of the Molecualr Pathology Centre, Montreal, QC, 2014

Opening of the Molecular Pathology Center, Montreal, QC, Canada, 2014

Lees meer